Strategy and innovation leading the PBM industry
At Prime, our success is determined by our ability to assess the critical role that PBMs play in today's dynamically changing health care landscape; and to respond, with strategy and purpose, to the shifting needs of our clients, employer groups and members.
Follow us in the media and read about the important issues facing us today and what we're doing to address them.
Prime Therapeutics names Jim DuCharme president and CEO (April 14, 2015)
Media Release Archive
Access our archive of media releases.